Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Non-cash Items (2021 - 2024)

Kezar Life Sciences (KZR) has disclosed Non-cash Items for 4 consecutive years, with $367000.0 as the latest value for Q3 2024.

  • Quarterly Non-cash Items rose 664.58% to $367000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $367000.0 through Sep 2024, up 664.58% year-over-year, with the annual reading at $118000.0 for FY2023, 99.06% down from the prior year.
  • Non-cash Items hit $367000.0 in Q3 2024 for Kezar Life Sciences, down from $12.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $80.2 million in Q1 2022 to a low of $48000.0 in Q3 2023.
  • Historically, Non-cash Items has averaged $21.3 million across 4 years, with a median of $12.5 million in 2021.
  • Biggest five-year swings in Non-cash Items: tumbled 99.81% in 2023 and later soared 968.38% in 2024.
  • Year by year, Non-cash Items stood at $77.4 million in 2021, then tumbled by 80.08% to $15.4 million in 2022, then plummeted by 99.23% to $118000.0 in 2023, then surged by 211.02% to $367000.0 in 2024.
  • Business Quant data shows Non-cash Items for KZR at $367000.0 in Q3 2024, $12.5 million in Q1 2024, and $118000.0 in Q4 2023.